Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Siemens Healthineers Ag ADR (OP: SMMNY )

29.60 -0.40 (-1.33%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jul 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,804
Open 29.86
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 30.00
Today's Range 29.60 - 29.95
52wk Range 23.80 - 31.73
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Siemens Layoffs 2024: What to Know About the Latest Siemens Job Cuts
Siemens Energy announced that it will cut 4,100 jobs from its Gamesa wind turbine division. What do you need to know about the Siemens layoffs? 
Via InvestorPlace
Topics Workforce
Exposures Layoff
GE HealthCare's Solid Demand And Sensible Margin Targets: Morgan Stanley Sees Potential Upside Despite Street's High Expectations
Morgan Stanley analyst Patrick Wood initiated coverage on GE HealthCare Technologies Inc (NASDAQ: GEHC) with an Equal-Weight rating and a  
Via Benzinga

Performance

YTD
+3.29%
+3.29%
1 Month
+3.50%
+3.50%
3 Month
+4.59%
+4.59%
6 Month
+3.33%
+3.33%
1 Year
+2.42%
+2.42%

More News

Read More
5 Top Stocks to Buy Now
Via The Motley Fool
Buy This Exceptional Stock Before Wall Street Finds Out
Via The Motley Fool
Own GE HealthCare Stock? Here's What You Need to Know About the Spin-Off
Via The Motley Fool
Elon Musk Dumps Another $3.6B Tesla Stock, Facebook's Jobs' Feature To Disappear Next Year, Foxconn Relaxes Covid Restrictions In China Factory: Today's Top Stories
Via Benzinga
Siemens Healthineers, GE Healthcare Studying Potential Deals With Medtronic's Spun Off Units
Via Benzinga
2 Breakout Growth Stocks to Buy for the Long Haul
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2021
Via Benzinga
Siemens' Fatty Liver Disease Blood Test Wins FDA De Novo Clearance
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.